Hayato Nagasawa

Combination therapy with corticosteroids, cyclosporin A, and intravenous pulse cyclophosphamide for acute/subacute interstitial pneumonia in patients with dermatomyositis.

Hideto Kameda, Hayato Nagasawa, Hiroe Ogawa et al. · PubMed · 2005 · 230 citations

Pharmacy, Pharmacology, Pharmacotherapy +14

Comparison of adding tocilizumab to methotrexate with switching to tocilizumab in patients with rheumatoid arthritis with inadequate response to methotrexate: 52-week results from a prospective, randomised, controlled study (SURPRISE study)

Yuko Kaneko, Tatsuya Atsumi, Yoshiya Tanaka et al. · Annals of the Rheumatic Diseases · 2016 · 113 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +15

Time‐dependent increased risk for serious infection from continuous use of tumor necrosis factor antagonists over three years in patients with rheumatoid arthritis

Ryoko Sakai, Yukiko Komano, Michi Tanaka et al. · Arthritis Care & Research · 2012 · 89 citations

Medicine, Internal Medicine, Pharmacotherapy +17

Clinical, radiographic and functional effectiveness of tocilizumab for rheumatoid arthritis patients--REACTION 52-week study

Tsutomu Takeuchi, Yoshiya Tanaka, Koichi Amano et al. · Lara D. Veeken · 2011 · 89 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Head-to-head comparison of the safety of tocilizumab and tumor necrosis factor inhibitors in rheumatoid arthritis patients (RA) in clinical practice: results from the registry of Japanese RA patients on biologics for long-term safety (REAL) registry

Ryoko Sakai, Soo‐Kyung Cho, Toshihiro Nanki et al. · Arthritis Research & Therapy · 2015 · 74 citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +17